Bob Douglass battled Multiple Myeloma courageously for over 8 years prior to passing away from the disease in April 2019. He was a fervent supporter of the MMRF from the time he was diagnosed in August of 2010. Bob passionately organized teams of walkers in both Chicago and Minnesota each fall to raise money for the MMRF. His dedication to the organization helped him to be recognized as the Spirit of Hope Recipient in Minneapolis in 2015. Thanks to the work of the MMRF, he was able to directly benefit from many of the treatments that were developed after his diagnosis. Unfortunately, his Myeloma progressed to the point where he was no longer responding to any of the available treatments and succumbed to the disease before a cure could be found.
Please honor Bob's memory by donating to this worthy organization. While a cure did not come in time for Bob, we are hopeful that through the work of the MMRF, a cure will come for others battling this terrible disease.
About the MMRF:
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. To learn more, visit themmrf.org.
For donations please mail to:
P.O. Box 414238
Boston, MA 02241-4238
383 Main Ave., 5th Floor
Norwalk, CT 06851
The MMRF is a registered 501(c)(3) non-profit.
Your contribution is tax deductible.